ORAL T-8 Oral Testosterone for Male Hormonal Contraception

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to test how the body absorbs a new form of oral testosterone (T). On Day 1 and Day 9 there are overnight stays in the General Clinical Research Center at the University of Washington to monitor blood testosterone levels over a 24-hour period.

Key facts

Study ID

NCT01167829

Run by

University of Washington

People needed

14

Starts

2010-07-01

Expected to finish

2012-06-01

Last updated by the study team

2013-09-06

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• able and willing to
• not participate in another drug study or donate blood, not take medications
• use contraception, comply with the protocol

You may not qualify if…

• abnormal evaluation, based on physical exam, medical history, blood tests (including serum chemistry, hematology, HIV, HCV, hormone levels)
• history or current use of alcohol, drug, steroid abuse, >3 alcohol drinks/day
• history of testicular disease, severe testicular trauma, major psychiatric disorder, bleeding disorders, current use of anti-coagulants or testosterone
• participation in hormonal drug study within past month

Where it is running

• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.